Vital Healthcare Property Trust (NZE:VHP) reported Thursday that its adjusted funds from operations per unit in the nine months to March 31 rose to NZ$0.0885, compared with the prior year's NZ$0.0778.
Net property income was NZ$119.2 million, compared with NZ$111.3 million a year earlier.
The board declared a quarterly dividend of NZ$0.024375 per share, unchanged from the prior corresponding period, payable June 5 to shareholders on record as of May 21.
Black Canyon's (ASX:BCA) ongoing beneficiation trials generated high-grade manganese oxide products with grades over 40% from blended low, medium, and high-grade Wandanya feeds through density-based heavy liquid separation, according to a Thursday filing with the Australian bourse.Blend one achieved manganese concentrations of nearly 42% and 45% from a 32% feed grade at densities of 2.8 grams per cubic centimeter (g/cm3) and 3.0 g/cm3. Blend two upgraded a 29% feed grade to 41% and nearly 44% manganese at the same densities.Manganese recoveries for both blends ranged from 73% to 82%, with low penalty elements in the beneficiated products, the filing said.
ALSOK (TYO:2331) and Carlyle-backed TCG2511 will launch a tender offer for Nippon Dry-Chemical (TYO:1909) at 3,730 yen per share, aiming to acquire all outstanding shares of the fire protection equipment maker, according to a Thursday filing on the Tokyo Stock Exchange.The offer will run from May 14 to June 29 and targets full ownership of the company, with a minimum acceptance threshold of 13.5 million shares and no upper limit. If the condition is met, the buyers plan a squeeze-out through share consolidation, potentially leading to delisting under exchange rules.ALSOK already holds about 16% of Nippon Dry-Chemical and has treated it as an equity-method affiliate since 2016. Carlyle, through the joint acquisition vehicle, holds no prior stake.The companies said they will retain ALSOK and Carlyle as the ultimate shareholders after a post-transaction restructuring involving a holding company, with ownership split roughly 51:49.Nippon Dry-Chemical's board has endorsed the tender offer and recommended shareholders tender their holdings after reviewing valuation, premium levels and strategic rationale.